Literature DB >> 30565908

Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment

David D. Kim1, Alasdair M. Barr1, Randall F. White1, William G. Honer1, Ric M. Procyshyn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30565908      PMCID： PMC6306284          DOI： 10.1503/jpn.180087

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  24 in total

1.  Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms.

Authors:  Vincenzo Villari; Tiziana Frieri; Andrea Fagiolini
Journal:  J Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.153

2.  Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.

Authors:  Frederike Schirmbeck; Daniela Mier; Christine Esslinger; Franziska Rausch; Susanne Englisch; Sarah Eifler; Andreas Meyer-Lindenberg; Peter Kirsch; Mathias Zink
Journal:  J Psychiatry Neurosci       Date:  2015-03       Impact factor: 6.186

3.  Obsessive-compulsive symptoms and clozapine.

Authors:  S M Dursun; M A Reveley
Journal:  Br J Psychiatry       Date:  1994-08       Impact factor: 9.319

4.  Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats.

Authors:  Vasileios Boulougouris; Jeffrey C Glennon; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

Review 5.  Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases.

Authors:  Lefteris Lykouras; Basil Alevizos; Panayiota Michalopoulou; Andreas Rabavilas
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-05       Impact factor: 5.067

6.  The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder.

Authors:  Shlomit Flaisher-Grinberg; Oded Klavir; Daphna Joel
Journal:  Int J Neuropsychopharmacol       Date:  2008-03-14       Impact factor: 5.176

7.  Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms.

Authors:  Jun Cai; Wen Zhang; Zhenghui Yi; Weihong Lu; Zhiguo Wu; Jun Chen; Shunying Yu; Yiru Fang; Chen Zhang
Journal:  Psychopharmacology (Berl)       Date:  2013-05-10       Impact factor: 4.530

8.  Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.

Authors:  Markus Dold; Martin Aigner; Rupert Lanzenberger; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-04       Impact factor: 5.176

Review 9.  Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism.

Authors:  Andrea de Bartolomeis; Carmine Tomasetti; Felice Iasevoli
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

10.  Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia.

Authors:  Emilio Fernandez-Egea; Yulia Worbe; Miguel Bernardo; Trevor W Robbins
Journal:  Psychol Med       Date:  2018-02-19       Impact factor: 7.723
View more
  4 in total

Review 1.  A Focused Review of the Metabolic Side-Effects of Clozapine.

Authors:  Jessica W Y Yuen; David D Kim; Ric M Procyshyn; William J Panenka; William G Honer; Alasdair M Barr
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

2.  Aripiprazole-induced obsessive-compulsive symptoms.

Authors:  Dilshana Nafisa; Anil Kakunje
Journal:  Ind Psychiatry J       Date:  2021-12-21

Review 3.  Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review.

Authors:  Maria Skokou; Eleni A Karavia; Zoi Drakou; Vassiliki Konstantinopoulou; Christina-Anna Kavakioti; Philippos Gourzis; Kyriakos E Kypreos; Ourania Andreopoulou
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-01

Review 4.  Pivotal mental states.

Authors:  Ari Brouwer; Robin Lester Carhart-Harris
Journal:  J Psychopharmacol       Date:  2020-11-11       Impact factor: 4.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.